Frontlight ResearchEarly access
Brain metastases trials in China
56 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleImmune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy
- Where
- Changsha
- Age
- 18 years and over
- People
- 140
- Run by
- Hunan Province Tumor Hospital
See details and how to joinNCT05584267 - No phaseTaking peoplea Feasibility Study of iHD-SRT for BM
- Where
- Shanghai
- People
- 35
- Run by
- Ruijin Hospital
See details and how to joinNCT06231186 - Phase 1/2Taking peopleWBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
- Where
- Shanghai
- Age
- 18 years and over
- People
- 56
- Run by
- Fudan University
See details and how to joinNCT06243003 - No phaseNot yet taking people in ChinaEfficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis
- Where
- Xi'an
- Age
- 18 years and over
- People
- 20
- Run by
- Xi'an International Medical Center Hospital
See details and how to joinNCT06015113 - Phase 3Taking peopleArmatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 300
- Run by
- Shanghai Cancer Hospital, China
See details and how to joinNCT05800223 - Phase 3Taking peopleEarly or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases
- Where
- Guangdong
- Age
- 18 years to 75 years
- People
- 232
- Run by
- Sun Yat-sen University
See details and how to joinNCT05768490